Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives

Cancer Treat Rev. 2024 Mar:124:102698. doi: 10.1016/j.ctrv.2024.102698. Epub 2024 Feb 11.


In the last years, theranostics has expanded the therapeutic options available for prostate cancer patients. In this review, we explore this dynamic field and its potential to revolutionize precision medicine for prostate cancer. We delve into the foundational principles, clinical applications, and emerging opportunities, emphasizing the potential synergy between radioligand therapy and other systemic treatments. Additionally, we address the ongoing challenges, including optimizing patient selection, assessing treatment responses, and determining the role of theranostics within the broader landscape of prostate cancer treatment.

Publication types

  • Review

MeSH terms

  • Humans
  • Male
  • Precision Medicine*
  • Prostatic Neoplasms* / therapy
  • Theranostic Nanomedicine